Trials / Completed
CompletedNCT01148147
Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty
Prevention of Cardiac and Vascular Periprocedural Complications in Patients Undergoing Coronary Angiography or Angioplasty: Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty. A Prospective Double-blind Randomized Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- Sponsor
- Azienda Ospedaliero Universitaria Maggiore della Carita · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of adenosin in elective patients undergoing coronary angioplasty.
Detailed description
This study will investigate the effects of adjunctive intracoronary administration of adenosine on periprocedural myocardial infarction as compared to placebo. This is a double-blind randomized trial single-center study. The enrollment will last 10 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adenosine | Intracoronary adenosine administration (180 ug for LCA and 120 ug for RCA) |
| DRUG | Placebo | Intracoronary Placebo administration |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2010-06-22
- Last updated
- 2011-11-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01148147. Inclusion in this directory is not an endorsement.